Atlas Trials

Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Clinical trial NCT00966940 · COMPLETED

Trial details

NCT number
NCT00966940
Sponsor
Alcon Research
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Glaucoma
Start date
2009-09-01
Primary completion
2010-03-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.